InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Thornberry Nancy, Director. Director active across 3 companies, notably Denali Therapeutics Inc.. In total, 14 disclosures have been recorded. Activity tracked since 8 January 2022. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Thornberry Nancy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
6,408 shares0Common StockSEC:0001797826-26-000002:0
5,997 shares0Common StockSEC:0001490978-25-000088:0
6,037 shares0Common StockSEC:0001714899-25-000137:0
398 shares0Common StockSEC:0000875320-25-000188:0
5,000 shares0Common StockSEC:0001490978-24-000056:0
5,967 shares0Common StockSEC:0001714899-24-000141:0
501 shares0Common StockSEC:0000875320-24-000131:0
1,136 shares0Common StockSEC:0000875320-23-000052:0
6,250 shares0Common StockSEC:0001490978-23-000081:0
4,216 shares0Common StockSEC:0001714899-23-000101:0
14,850 shares@ US$11.5274.1% of flowCommon StockSEC:0001490978-23-000050:0
4,950 shares@ US$11.5225.9% of flowCommon StockSEC:0001209191-22-045632:0
5,986 shares0Common StockSEC:0001714899-22-000091:0
627 shares0Common StockSEC:0001714899-22-000015:0
14 of 14 declarations
About Thornberry Nancy
Thornberry Nancy is Administrateur and has filed 14 filings in total. Across the 14 sampled recent filings, the period runs from 2022-01-11 to 2026-06-05, with transactions of nature Attribution, and the companies involved are Denali Therapeutics Inc., Schrodinger, Inc. and Vertex Pharmaceuticals INC / MA.
